心玮医疗-B中期报告 2023

Interim Report2023 5 17 24 25 26 28 29 31 43 3563813 33191901 6609 131 www.heartcare.com.cn 2021820 50191112 97927 H 1831717121716 881 2023109.642.9%(AIS) (VBP)(DRG)(DIP) 21FDA69.9 202363028.972.7%96.8%65.2%54.6 21NMPAFDA — Captor™CaptorNMPA202012CaptorCaptorCaptor Captor CaptorNMPA DEB20205DEBDEBNMPANMPA NMPA NMPANMPA NMPA —(AF)NMPA2022 NMPA 202383117263971218717116 A20221010202211920221024 2023630 202263076.742.9%2023630109.6AIS 202263025.8202363029.9 202263050.9202363079.7202263066.3%202363072.7% 202263021.6202363010.7(i)(ii) 202263060.9202363069.9 202263038.3202363029.8 202263036.0202363041.7 20236301.120226301.0 2023630202212315.0100.0%2023630202212314.3%3.9% 2023630694.620221231870.1 2023630978.2202212311,064.5 202363047.2202263023.8 2023630 20236305% 2023630 2023630453 2021H 2021H 20211112021H20226102021H2021H202110112022411 (a) 2021H(i)(ii)(iii) (a)(b)(c) (b) 2021H2021H (c) 2021HH (d) 2021H2021H20211112021H2021H2021H (e) (A) 2021H(i)202412312,700,000H(ii)63020222023202420252022100,000H300,000H 2021H (B) 2021H (f) (i)(ii)2021H(iii)(iv)2021H(v)2021H (vi)13.09(2)(a)XIVA (vii)60 (viii)30 (g) 2021HH3,000,000HH9.5%7.7%20231120236302021H2,717,3002,493,8402021H1% 2021H2021H2021H2021HH2021HHH (1) (2)B100%20241231 (3)202363032.6222.9613.25B100%20251231 H20218201,014.82021810 2023630 2023630 20236302022630 20236302023630 2C.2.12023630 2C.2.12C.2.1 3.212023630 2023630 24102023630 2022 ,2023320 ,2023320, 202213.51B(1) 13.2013.2113.22 2023831 2023630XV(i)XV78(ii)352(iii) (1)1,915,6901,915,690H (2)869,330869,330H697,158697,158H 2023630XV78352 2023630XV23336 (2)1,915,6901,915,690H (3)869,330869,330H697,158697,158H (4)906,220906,220H (5)Elbrus Investments Pte. Ltd.Elbrus1,627,907HElbrusTemasek Life Sciences Private LimitedTemasek Life Sciences Private LimitedFullerton Management Pte LtdFullertonManagement Pte LtdTemasek Holdings (Private) LimitedTemasek LifeSciences Private LimitedFullerton Management Pte LtdTemasek Holdings (Private) LimitedElbrus1,627,907HAranda Investments Pte. Ltd.140,000HSeletar Investments Pte LtdSeletar Investments Pte LtdTemasek Capital (Private) LimitedTemasek Capital (Private)LimitedAranda Investments Pte. Ltd140,000H (6)LYFE Columbia River LimitedLYFE Columbia152,5992,899,373HLYFE Ohio RiverLimitedLYFE Ohio49,147933,784HRaritan River65,1161,237,210HLYFE Capital Fund III (Dragon), L.P.227,300HLYFE ColumbiaLYFE Ohio LYFE CapitalFund III (Dragon), L.P.LYFE Capital Fund III (Dragon), L.P.LYFE Capital Management LimitedRaritan RiverLimitedRaritan RiverLYFE Capital Management LimitedLYFE Capital Management LimitedLYFE Capital Fund III (Dragon), L.P.LYFE ColumbiaLYFEOhioLYFE Capital Management LimitedLYFE ColumbiaLYFE OhioRaritan River 2023630XV23336 Ernst & Young27/F, One Taikoo Place979 King’s RoadQuarry Bay, Hong Kong 25422023630343434 2410 34 2023831 20236 30 20236 30 20236 30 1. 2016616202012320218203563813 2. 20236303420221231 3. 20221231 171717179–1281212— 20236 30 3. (a)12202311 (b)8202311 (c)1212202211202211 (i)7,265,000(ii)2022117,265,000 1220232022630 20236 30 3. (d)12—20231120231231 4. 8 5. 20236 30 5. 20236 30 6. 7. 20236 30 8. 9. 20236302022630 10. 20232022630 20232022630 20236 30 10. 11. 20236306,468,00020226308,055,000 2023630943,000202263096,0002022630 12. 20236 30 20236302.8%4.5% 14. 20236 30 14. 15. 20211112021H2021H2021H2023630187,000202263018,706,0005,0002022630326,950 16. 20236 30 17. (a) 18. 20236 30 18. 20236 30 18. 20221231 202363020221231 20236302022630 19. 20. 2023831